White House transparency disputes imperil funds to buy Covid therapeutics

Disputes over the White House’s lack of transparency are imperling its efforts to get more Covid-19 money — and the budget crunch is more severe than the administration has let…

WASHINGTON — The White House hasn’t publicly detailed exactly how it’s spent the more than $4 trillion Congress authorized for Covid-19 relief — and now, that lack of transparency could imperil its request for more money to fight the pandemic and buy therapeutics.

Amid heated negotiations over a government funding bill, three dozen Republican senators including Senate Minority Leader Mitch McConnell (R-Ky.) are refusing to consider more Covid-19 relief funding unless the federal government provides a full accounting of how funds have been spent. The White House disputes the accusations that there has been a lack of transparency, and an administration official said the White House briefs Congress on a regular and bipartisan basis about details of the status of relief funding.

Read the rest…